XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Reconciliation of net income to cash provided by operating activities:    
Net income $ 89,248 $ 60,944
Add (deduct):    
Depreciation and amortization 45,863 46,062
Adjustments for bad debt provisions 2,276 1,991
Net realized and unrealized gains (9,394) (11,238)
Amortization of net discount on debt securities investments (1,065) (460)
Payments for title losses less than (in excess of) provisions 2,908 (9,053)
Adjustments for insurance recoveries of title losses 0 208
Increase in receivables – net (23,524) (22,798)
Increase in other assets – net (21,735) (16,796)
Increase in accounts payable and other liabilities – net 13,217 3,912
Change in net deferred income taxes 5,380 5,199
Net income from equity method investments (1,683) (1,031)
Dividends received from equity method investments 1,371 848
Stock-based compensation expense 12,956 9,593
Other – net 328 275
Cash provided by operating activities 116,146 67,656
Investing activities:    
Proceeds from sales of investments in securities 44,306 34,276
Proceeds from matured investments in debt securities 67,972 78,849
Purchases of investments in securities (100,565) (99,169)
Net purchases of short-term investments (1,312) (5,206)
Purchases of property and equipment and other long-lived assets (46,165) (28,125)
Proceeds from sale of property and equipment and other assets 3,749 114
Cash paid for acquisition of businesses and related assets (38,553) (14,383)
Increase in notes receivable (21,718) (8,320)
Purchases of cost-basis and other investments (1,751) (31,110)
Other – net 1,995 1,487
Cash used by investing activities (92,042) (71,587)
Financing activities:    
Proceeds from notes payable 995 3,387
Payments on notes payable (1,115) (3,378)
Distributions to noncontrolling interests (10,445) (10,313)
Contributions from noncontrolling interests 0 54
Repurchases of Common Stock (3,565) (3,618)
Proceeds from stock option and employee stock purchase plan exercises 7,173 8,746
Cash dividends paid (42,618) (40,035)
Payment of contingent consideration related to acquisitions (5,087) (496)
Cash used by financing activities (54,662) (45,653)
Effects of changes in foreign currency exchange rates 2,778 (9)
Change in cash and cash equivalents (27,780) (49,593)
Cash and cash equivalents at beginning of period 216,298 233,365
Cash and cash equivalents at end of period $ 188,518 $ 183,772